Basic Information

Affiliated programs (koza)

• Graduate School of Pharmaceutical Sciences, 生体分子薬学, 助教

Professional Memberships

• From Feb. 2024

  日本蛋白質科学会
• From 2018

  The Japanese Society for Virology

Academic Degree

• 修士（理学）(北海道大学)
• 博士（生命科学）(北海道大学)

Academic Resume (Graduate Schools)

• 北海道大学, 大学院理学院生命理学専攻修士課程, 修了
• 北海道大学, 大学院生命科学院生命科学専攻博士課程, 修了

Academic Resume (Undergraduate School/Majors)

• 北海道大学, 理学部生物科学科, 卒業

Research History

• From May 2021, To Present

  Kyoto University, 医生物学研究所, 助教
• From Jul. 2018, To Apr. 2021

  九州大学大学院医学研究院, ウイルス学, 助教
• From Oct. 2014, To Jun. 2018

  Yale University, Molecular Biophysics & Biochemistry, Postdoctoral fellow

Language of Instruction

• Japanese

ID,URL

• J-Global ID

  201901008923595429

researchmap URL

• https://researchmap.jp/tsts

Research

Research Topics, Overview of the research

• Research Topics

  Structural analysis of the measles virus membrane fusion initiation complex to elucidate the mechanism of host cell infection

• Overview of the research

  The aim of this study is to elucidate the mechanism by which measles virus infects cells. To this end, we will prepare the H–F complex and determine its three-dimensional structure using X-ray crystallography. We will then compare the structure of the complex with the known structures of the individual proteins to develop a hypothesis regarding the mechanism that regulates membrane fusion. Finally, we will generate mutant viruses based on this hypothesis and test it through cell-based infection assays.

Research Areas

• Life sciences, Virology
• Life sciences, Structural biochemistry

Papers

• Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay

  Hesham Nasser; Ryo Shimizu; Jumpei Ito; Keita Matsuno; Naganori Nao; Hirofumi Sawa; Mai Kishimoto; Shinya Tanaka; Masumi Tsuda; Lei Wang; Yoshikata Oda; Marie Kato; Zannatul Ferdous; Hiromi Mouri; Kenji Shishido; Takasuke Fukuhara; Tomokazu Tamura; Rigel Suzuki; Hayato Ito; Daichi Yamasoba; Izumi Kimura; Naoko Misawa; Keiya Uriu; Yusuke Kosugi; Shigeru Fujita; Mai Suganami; Mika Chiba; Ryo Yoshimura; So Nakagawa; Jiaqi Wu; Akifumi Takaori-Kondo; Kotaro Shirakawa; Kayoko Nagata; Yasuhiro Kazuma; Ryosuke Nomura; Yoshihito Horisawa; Yusuke Tashiro; Yugo Kawai; Takashi Irie; Ryoko Kawabata; MST Monira Begum; Otowa Takahashi; Kimiko Ichihara; Takamasa Ueno; Chihiro Motozono; Mako Toyoda; Yuri L. Tanaka; Erika P. Butlertanaka; Maya Shofa; Kazuo Takayama; Rina Hashimoto; Sayaka Deguchi; Takao Hashiguchi; Tateki Suzuki; Kanako Kimura; Jiei Sasaki; Yukari Nakajima; Kaori Tabata; Akatsuki Saito; Kei Sato; Terumasa Ikeda

  STAR Protocols, Dec. 2022

  
• A Short Peptide Inhibitor of Measles Virus Fusion Protein that Exhibits Passive Membrane Permeability.

  Ziwei Gao; Jiei Sasaki; Tateki Suzuki; Shinsuke Sando; Takao Hashiguchi; Jumpei Morimoto

  ChemMedChem, 28 Jul. 2025

  Access this paper :

  
• Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants.

  Yuki Anraku; Shunsuke Kita; Taishi Onodera; Akihiko Sato; Takashi Tadokoro; Shiori Ito; Yu Adachi; Ryutaro Kotaki; Tateki Suzuki; Jiei Sasaki; Nozomi Shiwa-Sudo; Naoko Iwata-Yoshikawa; Noriyo Nagata; Souta Kobayashi; Yasuhiro Kazuki; Mitsuo Oshimura; Takao Nomura; Michihito Sasaki; Yasuko Orba; Tadaki Suzuki; Hirofumi Sawa; Takao Hashiguchi; Hideo Fukuhara; Yoshimasa Takahashi; Katsumi Maenaka

  Communications biology, 22 Mar. 2025

  
• Discovery of potent measles virus fusion inhibitor peptides via structure-guided derivatization.

  Ziwei Gao; Jiei Sasaki; Tateki Suzuki; Tomoaki Suzuki; Yuki Miwa; Shinsuke Sando; Takao Hashiguchi; Jumpei Morimoto

  RSC medicinal chemistry, 24 Jan. 2025

  Access this paper :

  
• Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.

  Saya Moriyama; Yuki Anraku; Shunta Taminishi; Yu Adachi; Daisuke Kuroda; Shunsuke Kita; Yusuke Higuchi; Yuhei Kirita; Ryutaro Kotaki; Keisuke Tonouchi; Kohei Yumoto; Tateki Suzuki; Taiyou Someya; Hideo Fukuhara; Yudai Kuroda; Tsukasa Yamamoto; Taishi Onodera; Shuetsu Fukushi; Ken Maeda; Fukumi Nakamura-Uchiyama; Takao Hashiguchi; Atsushi Hoshino; Katsumi Maenaka; Yoshimasa Takahashi

  Nature communications, 14 Jul. 2023

  
• Structural delineation of SARS-CoV-2 broadly neutralizing antibody to Omicron subvariants including BA.4/BA.5 and BA.2.75

  Saya Moriyama; Yuki Anraku; Shunta Taminishi; Yu Adachi; Daisuke Kuroda; Shunsuke Kita; Yusuke Higuchi; Ryutaro Kotaki; Keisuke Tonouchi; Kohei Yumoto; Tateki Suzuki; Taiyou Someya; Hideo Fukuhara; Yudai Kuroda; Tsukasa Yamamoto; Taishi Onodera; Shuetsu Fukushi; Ken Maeda; Fukumi Nakamura-Uchiyama; Takao Hashiguchi; Atsushi Hoshino; Katsumi Maenaka; Yoshimasa Takahashi

  21 Dec. 2022

  
• Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope

  Keisuke Tonouchi; Yu Adachi; Tateki Suzuki; Daisuke Kuroda; Ayae Nishiyama; Kohei Yumoto; Haruko Takeyama; Tadaki Suzuki; Takao Hashiguchi; Yoshimasa Takahashi

  PLOS Pathogens, 09 Aug. 2023

  
• Interaction of the Hemagglutinin Stalk Region with Cell Adhesion Molecule (CADM) 1 and CADM2 Mediates the Spread between Neurons and Neuropathogenicity of Measles Virus with a Hyperfusogenic Fusion Protein

  Ryuichi Takemoto; Yuichi Hirai; Shumpei Watanabe; Hidetaka Harada; Tateki Suzuki; Takao Hashiguchi; Yusuke Yanagi; Yuta Shirogane

  Journal of Virology, May 2023, Peer-reviewed

  
• Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant.

  Jumpei Ito; Rigel Suzuki; Keiya Uriu; Yukari Itakura; Jiri Zahradnik; Kanako Terakado Kimura; Sayaka Deguchi; Lei Wang; Spyros Lytras; Tomokazu Tamura; Izumi Kida; Hesham Nasser; Maya Shofa; Mst Monira Begum; Masumi Tsuda; Yoshitaka Oda; Tateki Suzuki; Jiei Sasaki; Kaori Sasaki-Tabata; Shigeru Fujita; Kumiko Yoshimatsu; Hayato Ito; Naganori Nao; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Yuki Yamamoto; Tetsuharu Nagamoto; Jin Kuramochi; Gideon Schreiber; Akatsuki Saito; Keita Matsuno; Kazuo Takayama; Takao Hashiguchi; Shinya Tanaka; Takasuke Fukuhara; Terumasa Ikeda; Kei Sato

  Nature communications, 11 May 2023

  Access this paper :

  
• Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.

  Izumi Kimura; Daichi Yamasoba; Tomokazu Tamura; Naganori Nao; Tateki Suzuki; Yoshitaka Oda; Shuya Mitoma; Jumpei Ito; Hesham Nasser; Jiri Zahradnik; Keiya Uriu; Shigeru Fujita; Yusuke Kosugi; Lei Wang; Masumi Tsuda; Mai Kishimoto; Hayato Ito; Rigel Suzuki; Ryo Shimizu; Mst Monira Begum; Kumiko Yoshimatsu; Kanako Terakado Kimura; Jiei Sasaki; Kaori Sasaki-Tabata; Yuki Yamamoto; Tetsuharu Nagamoto; Jun Kanamune; Kouji Kobiyama; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Kotaro Shirakawa; Akifumi Takaori-Kondo; Jin Kuramochi; Gideon Schreiber; Ken J Ishii; Takao Hashiguchi; Terumasa Ikeda; Akatsuki Saito; Takasuke Fukuhara; Shinya Tanaka; Keita Matsuno; Kei Sato

  Cell, 13 Oct. 2022, Peer-reviewed, Lead author

  
• Collective fusion activity determines neurotropism of an en bloc transmitted enveloped virus.

  Yuta Shirogane; Hidetaka Harada; Yuichi Hirai; Ryuichi Takemoto; Tateki Suzuki; Takao Hashiguchi; Yusuke Yanagi

  Science advances, 27 Jan. 2023

  Access this paper :

  
• Application of Acoustic Ejection MS System to High-Throughput Screening for SARS-CoV-2 3CL Protease Inhibitors.

  Tsukasa Hasegawa; Riyo M Imamura; Tateki Suzuki; Takao Hashiguchi; Takao Nomura; Satoko Otsuguro; Katsumi Maenaka; Michihito Sasaki; Yasuko Orba; Hirofumi Sawa; Akihiko Sato; Takayoshi Okabe; Tetsuo Nagano; Hirotatsu Kojima

  Chemical & pharmaceutical bulletin, 01 Mar. 2022

  
• A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site.

  Taishi Onodera; Shunsuke Kita; Yu Adachi; Saya Moriyama; Akihiko Sato; Takao Nomura; Shuhei Sakakibara; Takeshi Inoue; Takashi Tadokoro; Yuki Anraku; Kohei Yumoto; Cong Tian; Hideo Fukuhara; Michihito Sasaki; Yasuko Orba; Nozomi Shiwa; Naoko Iwata; Noriyo Nagata; Tateki Suzuki; Jiei Sasaki; Tsuyoshi Sekizuka; Keisuke Tonouchi; Lin Sun; Shuetsu Fukushi; Hiroyuki Satofuka; Yasuhiro Kazuki; Mitsuo Oshimura; Tomohiro Kurosaki; Makoto Kuroda; Yoshiharu Matsuura; Tadaki Suzuki; Hirofumi Sawa; Takao Hashiguchi; Katsumi Maenaka; Yoshimasa Takahashi

  Immunity, 12 Oct. 2021, Peer-reviewed

  
• Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19.

  Yu Kaku; Takeo Kuwata; Hasan Md Zahid; Takao Hashiguchi; Takeshi Noda; Noriko Kuramoto; Shashwata Biswas; Kaho Matsumoto; Mikiko Shimizu; Yoko Kawanami; Kazuya Shimura; Chiho Onishi; Yukiko Muramoto; Tateki Suzuki; Jiei Sasaki; Yoji Nagasaki; Rumi Minami; Chihiro Motozono; Mako Toyoda; Hiroshi Takahashi; Hiroto Kishi; Kazuhiko Fujii; Tsuneyuki Tatsuke; Terumasa Ikeda; Yosuke Maeda; Takamasa Ueno; Yoshio Koyanagi; Hajime Iwagoe; Shuzo Matsushita

  Cell reports, 13 Jul. 2021

  
• Short-Stalk Isoforms of CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Interacting with the Viral Hemagglutinin

  Ryuichi Takemoto; Tateki Suzuki; Takao Hashiguchi; Yusuke Yanagi; Yuta Shirogane

  Journal of Virology, 09 Feb. 2022

  
• CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in cis

  Yuta Shirogane; Ryuichi Takemoto; Tateki Suzuki; Tomonori Kameda; Kinichi Nakashima; Takao Hashiguchi; Yusuke Yanagi

  Journal of Virology, 24 Jun. 2021

  
• Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

  Hirofumi Ohashi; Koichi Watashi; Wakana Saso; Kaho Shionoya; Shoya Iwanami; Takatsugu Hirokawa; Tsuyoshi Shirai; Shigehiko Kanaya; Yusuke Ito; Kwang Su Kim; Takao Nomura; Tateki Suzuki; Kazane Nishioka; Shuji Ando; Keisuke Ejima; Yoshiki Koizumi; Tomohiro Tanaka; Shin Aoki; Kouji Kuramochi; Tadaki Suzuki; Takao Hashiguchi; Katsumi Maenaka; Tetsuro Matano; Masamichi Muramatsu; Masayuki Saijo; Kazuyuki Aihara; Shingo Iwami; Makoto Takeda; Jane A. McKeating; Takaji Wakita

  iScience, Apr. 2021

  
• Molecular Mechanism of the Flexible Glycan Receptor Recognition by Mumps Virus

  Marie Kubota; Rei Matsuoka; Tateki Suzuki; Koji Yonekura; Yusuke Yanagi; Takao Hashiguchi

  Journal of Virology, Aug. 2019

  
• A Facile Method for Producing Selenocysteine-Containing Proteins.

  Mukai T; Sevostyanova A; Suzuki T; Fu X; Söll D

  Angewandte Chemie (International ed. in English), Jun. 2018, Peer-reviewed

  
• Eine einfache Methode zur Produktion von Selenoproteinen

  Mukai T; Sevostyanova A; Suzuki T; Fu X; Söll D

  Angewandte Chemie, May 2018, Peer-reviewed

  
• Crystal structures reveal an elusive functional domain of pyrrolysyl-tRNA synthetase

  Tateki Suzuki; Corwin Miller; Li-Tao Guo; Joanne M. L. Ho; David Bryson; Yane-Shih Wang; David R. Liu; Dieter Soll

  NATURE CHEMICAL BIOLOGY, Dec. 2017, Peer-reviewed, Lead author

  
• A [3Fe-4S] cluster is required for tRNA thiolation in archaea and eukaryotes

  Yuchen Liu; David J. Vinyard; Megan E. Reesbeck; Tateki Suzuki; Kasidet Manakongtreecheep; Patrick L. Holland; Gary W. Brudvig; Dieter Soll

  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Nov. 2016, Peer-reviewed

  
• Template-dependent nucleotide addition in the reverse (3'-5') direction by Thg1-like protein

  Shoko Kimura; Tateki Suzuki; Meirong Chen; Koji Kato; Jian Yu; Akiyoshi Nakamura; Isao Tanaka; Min Yao

  SCIENCE ADVANCES, Mar. 2016, Peer-reviewed, Lead author

  
• Pyrrolysyl-tRNA Synthetase, an Aminoacyl-tRNA Synthetase for Genetic Code Expansion

  Ana Crnkovic; Tateki Suzuki; Dieter Soll; Noah M. Reynolds

  CROATICA CHEMICA ACTA, 2016, Peer-reviewed

  
• Structure of the Pseudomonas aeruginosa transamidosome reveals unique aspects of bacterial tRNA-dependent asparagine biosynthesis

  Tateki Suzuki; Akiyoshi Nakamura; Koji Kato; Dieter Soell; Isao Tanaka; Kelly Sheppard; Min Yao

  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, Jan. 2015, Peer-reviewed, Lead author

  
• Human NAT10 Is an ATP-dependent RNA Acetyltransferase Responsible for N-4-Acetylcytidine Formation in 18 S Ribosomal RNA (rRNA)

  Satoshi Ito; Sayuri Horikawa; Tateki Suzuki; Hiroki Kawauchi; Yoshikazu Tanaka; Takeo Suzuki; Tsutomu Suzuki

  JOURNAL OF BIOLOGICAL CHEMISTRY, Dec. 2014, Peer-reviewed

  
• Crystallization and preliminary X-ray crystallographic analysis of a bacterial Asn-transamidosome

  Tateki Suzuki; Keitaro Yamashita; Yoshikazu Tanaka; Isao Tanaka; Min Yao

  Acta Crystallographica Section F:Structural Biology Communications, 2014, Peer-reviewed, Lead author

  
• RNA helicase module in an acetyltransferase that modifies a specific tRNA anticodon

  Sarin Chimnaronk; Tateki Suzuki; Tetsuhiro Manita; Yoshiho Ikeuchi; Min Yao; Tsutomu Suzuki; Isao Tanaka

  EMBO JOURNAL, May 2009, Peer-reviewed

  

Misc.

• 新型コロナウイルスに対するscFv化抗体の機能評価

  染谷太陽; 谷秀顕; 安楽佑樹; 田聡; 福原秀雄; 福原秀雄; 野村尚生; 田所高志; 小野寺大志; 安達悠; 森山彩野; 湯本航平; 鈴木干城; 佐々木慈英; 橋口隆生; 高橋宜聖; 喜多俊介; 前仲勝実; 前仲勝実

  日本蛋白質科学会年会プログラム・要旨集, 2023

  
• 汎SARS-CoV-2抗体の中和機構とBA.4/5変異株によるACE2受容体認識機構の構造基盤

  鈴木干城; 安楽佑樹; 木村香菜子; 喜多俊介; 佐々木慈英; 小澤龍彦; 仁井見英樹; 佐藤佳; 前仲勝実; 橋口隆生

  日本ウイルス学会学術集会プログラム・予稿集(Web), 2022

  
• シミアンウイルス41由来hemagglutinin-neuraminidaseのX線結晶構造解析

  千葉拓実; 鈴木干城; 橋口隆生

  日本蛋白質科学会年会(Web), 2024

  
• 膜融合トリガー型ヘマグルチニンストークの構造解析から考察されるモルビリウイルスの膜融合活性化メカニズム

  鈴木干城; 柳雄介; 橋口隆生

  日本分子生物学会年会プログラム・要旨集(Web), 2024

  
• SARS-CoV-2BQ.1.1変異株Sタンパク質RBDによるACE2受容体認識と抗体逃避の構造基盤

  木村香菜子; 鈴木干城; 佐々木慈英; 佐藤佳; 橋口隆生

  日本蛋白質科学会年会(Web), 2024

  
• Structural basis for ACE2 receptor recognition and antibody escape by SARS-CoV-2 BQ.1.1 mutant S protein RBD

  木村香菜子; 鈴木干城; 佐々木慈英; 佐藤佳; 橋口隆生

  日本ウイルス学会学術集会プログラム・予稿集(Web), 2023

  

Presentations

• Structural basis for membrane fusion triggered by morbillivirus hemagglutinin

  Tateki Suzuki

  Strengthening France-Japan Collaboration in Virology : a Workshop on Emerging Viruses and Pandemic Preparedness, 10 Oct. 2025

  
• Structural basis for membrane fusion triggered by morbillivirus hemagglutinin

  Tateki Suzuki

  The 20th International Symposium of the Institute Network for Biomedical Sciences in Kyoto, 02 Oct. 2025

  
• Fusion-triggering structures of the morbillivirus hemagglutinin stalk provide an insight into the mechanism of fusion activation

  鈴木 干城; 栁 祐介; 橋口隆生

  第47回 日本分子生物学会年会, 27 Nov. 2024, Invited

  
• Crystal structure of the H protein stalk domain proposes a mechanism of F protein activation in morbilliviruses

  鈴木干城; 柳雄介; 橋口隆生

  第70回日本ウイルス学会学術集会, Sep. 2023

  
• Fusion-triggering structures of the morbillivirus hemagglutinin stalk provide an insight into the mechanism of fusion activation.

  鈴木 干城; 柳 雄介; 橋口 隆生

  第71回日本ウイルス学会学術集会, Nov. 2024

  
• Fusion-triggering structures of the morbillivirus hemagglutinin stalk provide an insight into the mechanism of fusion activation.

  Suzuki T.; Yanagi Y.; Hashiguchi T.

  The 22nd Awaji International Forum on Infection and Immunity, Sep. 2024, Invited

  

External funds: Kakenhi

• Structural basis for the measles virus membrane fusion initiation complex

  Grant-in-Aid for Early-Career Scientists

  Basic Section 43020:Structural biochemistry-related

  Kyoto University;Kyushu University

  Tateki Suzuki

  From 01 Apr. 2019, To 31 Mar. 2024, Project Closed

  麻疹ウイルス;ヘマグルチニン;膜融合;X線結晶構造解析;構造生物学;モルビリウイルス;感染症;ウイルス;麻疹

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-19K16057/
• Structural Basis of Measles Virus Infection of the Brain Leading to Central Nervous System Disease

  Grant-in-Aid for Early-Career Scientists

  Basic Section 43020:Structural biochemistry-related

  Kyoto University

  Tateki Suzuki

  From 01 Apr. 2022, To 31 Mar. 2025, Project Closed

  麻疹ウイルス;ヘマグルチニン;膜融合;X線結晶構造解析;構造生物学;イヌジステンパーウイルス;ネコモルビリウイルス;モルビリウイルスウイルス;麻疹;犬ジステンパー;受容体;SSPE

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K15047/
• 受容体とがん細胞表面分子の構造共通性に着目した腫瘍溶解麻疹ウイルスの機能拡張

  Grant-in-Aid for Scientific Research (C)

  Basic Section 43040:Biophysics-related

  Kyoto University

  鈴木 干城

  From 01 Apr. 2024, To 31 Mar. 2027, Granted

  麻疹ウイルス;腫瘍溶解ウイルス;受容体;SLAM;Nectin-4;膜融合

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24K09394/

External funds: others

• COVID-19治療薬シードの探索と構造基盤の解明

  上原記念生命科学財団　研究奨励金

  From 15 Feb. 2021, To 31 Mar. 2022

  鈴木干城
• 新型コロナウイルス（SARS-CoV-2）を含む汎ベータコロナウイルス細胞侵入阻害薬の研究

  三井住友銀行　「新型コロナワクチン・治療薬開発寄付講座」寄付事業

  From 01 Oct. 2020, To 31 Mar. 2021

  鈴木干城

Education

Teaching subject(s)

• From 01 Apr. 2026, To 31 Mar. 2027

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2026, To 31 Mar. 2027

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2026, To 31 Mar. 2027

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2026, To 31 Mar. 2027

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2026, To 31 Mar. 2027

  Medicinal Frontier Science Research C

  8408, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2026, To 31 Mar. 2027

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2026, To 31 Mar. 2027

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2026, To 31 Mar. 2027

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Frontier Science Research C

  8408, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2025, To 31 Mar. 2026

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  ILAS Seminar

  Z001, Spring, Institute for Liberal Arts and Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Medicinal Frontier Science Research C

  8408, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Medical Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2022, To 31 Mar. 2023

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1

Administration

Faculty management (title, position)

• From 01 Apr. 2023

  共同利用機器等委員会　委員
• From 01 Apr. 2022, To 31 Mar. 2023

  令和４年度医⽣物学研究所教員会議運営委員
• From May 2021

  化学物質管理委員会　委員